V. Poletti (Forli, Italy), C. Cordeiro (Coimbra, Portugal)
Contribute of BAL proteomic analysis in sarcoidosis (S) and in idiopathic pulmonary fibrosis (IPF/UIP)
R. Paola, B. Elena, C. Riccardo, N. Nikolaos, P. Maria Grazia, B. Luca, M. Barbara (Siena, Italy)
|  |
MMPs in BAL from patients with scleroderma fibrosing alveolitis
H. M. Branley, H. A. Jones, R. M. du Bois (London, United Kingdom)
| |
Increased expression of tumor necrosis factor receptors by bronchoalveolar cells in cryptogenic organising pneumonia
Q. Ye, U. Costabel, J. Guzman (Essen, Bochum, Germany)
| |
Long term follow up of the whole lung lavage programme in patients with pulmonary alveolar proteinosis: an update
M. Luisetti, G. Stella, I. Campo, G. Rodi, A. Corsico, M. Ceruti, R. Dore, I. Cerveri, B. C. Trapnell, E. Pozzi (Pavia, Italy; Cincinnati, United States Of America)
|  |
Lysozyme level and activity are decreased in the lungs of patients with idiopathic pulmonary fibrosis (IPF) and potentially contribute to increased susceptibility to pulmonary infection
P. Markart, M. Wygrecka, C. Ruppert, T. Koledachkina, W. Seeger, A. Guenther (Giessen, Germany)
| |
Identification of four proteins from a "sarcoidosis-associated protein profile": SELDI-TOF MS analysis of bronchoalveolar lavage fluid (BALF)
E. Kriegova, C. Melle, Z. Navratilova, V. Kolek, R. M. du Bois, F. von Eggeling, M. Petrek (Olomouc, Czech Republic; Jena, Germany; London, United Kingdom)
| |
The role of apoptosis in idiopathic pulmonary alveolar proteinosis
F. C. Lin, Y. C. Chen, C. C. Chang (Taipei, Taiwan, Province Of China)
| |
Changes of BAL findings as no progression marker in idiopathic pulmonary fibrosis (IPF) patients treated with IFN-g
I. Esposito, M. Bocchino, F. Stefanelli, B. Bellofiore, F. Perna, M. Galgani, A. Ponticiello, A. Sanduzzi (Naples, Italy)
| |